Correlation Between Camurus AB and Ascelia Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Camurus AB and Ascelia Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Camurus AB and Ascelia Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Camurus AB and Ascelia Pharma AB, you can compare the effects of market volatilities on Camurus AB and Ascelia Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Camurus AB with a short position of Ascelia Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Camurus AB and Ascelia Pharma.

Diversification Opportunities for Camurus AB and Ascelia Pharma

-0.61
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Camurus and Ascelia is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Camurus AB and Ascelia Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascelia Pharma AB and Camurus AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Camurus AB are associated (or correlated) with Ascelia Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascelia Pharma AB has no effect on the direction of Camurus AB i.e., Camurus AB and Ascelia Pharma go up and down completely randomly.

Pair Corralation between Camurus AB and Ascelia Pharma

Assuming the 90 days trading horizon Camurus AB is expected to under-perform the Ascelia Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Camurus AB is 2.02 times less risky than Ascelia Pharma. The stock trades about -0.04 of its potential returns per unit of risk. The Ascelia Pharma AB is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  220.00  in Ascelia Pharma AB on November 2, 2024 and sell it today you would earn a total of  66.00  from holding Ascelia Pharma AB or generate 30.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Camurus AB  vs.  Ascelia Pharma AB

 Performance 
       Timeline  
Camurus AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Camurus AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Camurus AB is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Ascelia Pharma AB 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Ascelia Pharma AB are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain technical and fundamental indicators, Ascelia Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.

Camurus AB and Ascelia Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Camurus AB and Ascelia Pharma

The main advantage of trading using opposite Camurus AB and Ascelia Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Camurus AB position performs unexpectedly, Ascelia Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascelia Pharma will offset losses from the drop in Ascelia Pharma's long position.
The idea behind Camurus AB and Ascelia Pharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
FinTech Suite
Use AI to screen and filter profitable investment opportunities